Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Clinical trial NCT06188741 · RECRUITING
Trial details
- NCT number
- NCT06188741
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-27
- Primary completion
- 2031-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.